MRMDOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
MARIMED INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.06−0.00 (-3.39%)
Close on Oct 19, 2026
- Market cap
- $22.78M
- P/E (TTM)
- –
- Dividend yield
- –
Marimed statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Medicinal Chemicals & Botanical Products companies for comparison
Valuation
| Measure | Marimed | Industry median |
|---|---|---|
| Market Cap | $22.97M | $197.05M |
| Enterprise Value | $12.63M | $106.56M |
| PS Ratio | 0.14 | 3.93 |
| P/FCF Ratio | 2.87 | 18.25 |
| P/OCF Ratio | 2.48 | 13.78 |
Enterprise value
| Measure | Marimed | Industry median |
|---|---|---|
| EV / Sales | 0.08 | 2.69 |
| EV / EBITDA | 2.01 | 14.86 |
| EV / FCF | 1.58 | 21.02 |
Income (trailing twelve months)
| Measure | Marimed | Industry median |
|---|---|---|
| Revenue | $163.82M | $57.94M |
| Gross Profit | $58.37M | $90.47M |
| Operating Income | -$2.38M | -$21.44M |
| Pretax Income | -$10.18M | -$14.45M |
| Net Income | -$14.95M | -$22.46M |
| EBITDA | $6.29M | -$16.91M |
| EPS (Diluted) | -$0.04 | -$0.83 |
Margins
| Measure | Marimed | Industry median |
|---|---|---|
| Gross Margin | 35.6% | 52.3% |
| Operating Margin | -1.45% | -44.5% |
| Pretax Margin | -6.21% | -13.0% |
| Profit Margin | -9.13% | -39.2% |
| EBITDA Margin | 3.84% | -31.3% |
| FCF Margin | 4.89% | -8.85% |
Returns
| Measure | Marimed | Industry median |
|---|---|---|
| Return on Assets (ROA) | -7.45% | -41.0% |
| Return on Capital Employed (ROCE) | -1.79% | -37.8% |
Growth
| Measure | Marimed | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 4.37% | 6.01% |
| Revenue Growth (3Y CAGR) | 6.05% | 2.25% |
| Revenue Growth (5Y CAGR) | 25.7% | 6.42% |
Balance sheet
| Measure | Marimed | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $8.44M | $62.42M |
| Net Cash (Debt) | $8.44M | $15.68M |
| Net Cash Per Share | $0.02 | $0.65 |
| Working Capital | -$5.32M | $75.77M |
Financial position
| Measure | Marimed | Industry median |
|---|---|---|
| Current Ratio | 0.92 | 3.30 |
| Quick Ratio | 0.28 | 2.39 |
| Interest Coverage | -0.30 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Marimed | Industry median |
|---|---|---|
| Operating Cash Flow | $9.27M | -$12.35M |
| Capital Expenditures | -$1.26M | -$1.06M |
| Free Cash Flow | $8.01M | -$20.28M |
| FCF Per Share | $0.02 | -$0.41 |
Efficiency
| Measure | Marimed | Industry median |
|---|---|---|
| Asset Turnover | 0.82 | 0.38 |
| Inventory Turnover | 2.79 | 2.67 |
| Revenue Per Employee | $177.49K | $398.96K |
| Profits Per Employee | -$16.20K | -$732.08K |
| Employee Count | 923 | 73 |
Dividends and yields
| Measure | Marimed | Industry median |
|---|---|---|
| Earnings Yield | -65.1% | -21.2% |
| FCF Yield | 34.9% | -7.64% |
Shares
| Measure | Marimed | Industry median |
|---|---|---|
| Shares Outstanding | 403,041,000 | 59,128,900 |
| Shares Change (YoY) | 3.30% | 11.1% |
| Shares Change (QoQ) | 0.57% | 0.54% |
| Float | 359,052,000 | 48,744,500 |
| Shares Held by Insiders | 10.9% | 11.8% |
| Shares Held by Institutions | 0.16% | 59.4% |
Taxes
| Measure | Marimed | Industry median |
|---|---|---|
| Income Tax | $4.74M | $91.50K |
Scores
| Measure | Marimed | Industry median |
|---|---|---|
| Altman Z-Score | -0.11 | 0.10 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from Marimed's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.